Related Experiment Video
Updated: Jul 15, 2026
07:13
Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Valproic acid, a molecular lead to multiple regulatory pathways
M Kostrouchová1, Z Kostrouch, M Kostrouchová
1Laboratory of Molecular Pathology, Institute of Inherited Metabolic Disorders of the 1st Faculty of Medicine, Charles University, Prague, Czech Republic. marta.kostrouchova@lfl.cuni.cz
Folia Biologica
|April 24, 2007
Summary
Valproic acid, used for epilepsy, shows potential as an anticancer drug by affecting cancer cell growth and multiple regulatory pathways. This offers new avenues for developing targeted cancer therapies.
Area of Science:
- Pharmacology
- Oncology
- Developmental Biology
Background:
- Valproic acid (2-propyl pentanoic acid) is a established treatment for epilepsy and bipolar disorder.
- Rare developmental side effects suggest interference with cellular regulatory pathways.
- Emerging data indicate valproic acid impacts cancer cell behavior.
Purpose of the Study:
- To explore the multifaceted effects of valproic acid on cancer cells.
- To identify the specific molecular mechanisms targeted by valproic acid.
- To evaluate valproic acid's potential as an anticancer therapeutic and drug lead.
Main Methods:
- Analysis of valproic acid's effects on cancer cell growth, differentiation, apoptosis, and immunogenicity.
- Investigation of its interference with key regulatory pathways including histone deacetylases, GSK3, Akt, ERK, phosphoinositol pathway, TCA cycle, GABA, and OXPHOS.
- Review of existing data on valproic acid's molecular interactions.
Main Results:
- Valproic acid influences cancer cell proliferation, differentiation, programmed cell death, and immune response.
- It interacts with a broad spectrum of molecular targets crucial for cell regulation.
- These targets include epigenetic modifiers, signaling kinases, metabolic pathways, and neurotransmitter systems.
Conclusions:
- Valproic acid demonstrates significant potential as an anticancer agent.
- It serves as a valuable molecular tool for understanding cancer biology.
- Its diverse mechanisms offer opportunities for designing novel, targeted cancer therapies.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...